Robot-Assisted surgery for lung cancer and thymus disease put to the test

NCT ID NCT05150210

Ongoing Disease control Sponsor: Intuitive Surgical Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a new robotic surgery system, the da Vinci SP, for removing part or all of a lung (lobectomy) or the thymus gland (thymectomy) in people with lung cancer, benign lung disease, thymoma, or myasthenia gravis. The goal is to see if the robot can perform these surgeries safely without needing to switch to a different method. Thirty-two adults will be enrolled and followed for 30 days after surgery, with long-term follow-up for up to 5 years.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: da Vinci SP Surgical System (robotic-assisted surgery device)
What this could lead to: If successful, this could show that the da Vinci SP robot is a safe and effective tool for minimally invasive lung and thymus surgeries.
What could go wrong: This is a small, early-stage study with only 32 participants, so results may not apply to everyone. There are always risks with surgery, such as complications or the need to switch to a different approach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN LUNG DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung cancer lung disorder myasthenia gravis thymoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN LUNG DISEASE MYASTHENIA GRAVIS PRIMARY LUNG CANCER THYMOMA

Contacts and locations

Locations

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States
Cedars-Sinai Medical Center

Los Angeles, California, 90048, United States
Duke University Hospital

Durham, North Carolina, 27710, United States
MD Anderson Cancer Center

Houston, Texas, 77030, United States
Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States
NYU Langone Health

New York, New York, 10016, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.